-
The role of pirnas in oncogenesis: a review of associations
DOI 10.31917/2501074
S.M. Shlyapnikov, A.A. Agumava, A.V. Panchenko, S.V. Orlov
-
Modern approa hes to the treatment of primary multiple unilateral synchronous lung tumors (literature review)
DOI 10.31917/2501063
I.V. Mosin, S.M. Nuraliev, A.G. Pavlov, V.M. Moiseenko
-
Comparative evaluation of robot-assisted, laparoscopic and open surgical interventions in the combined treatment of stomach cance
DOI 10.31917/2501049
S.A. Kovalenko., I.I. Dzidzava, D.V. Gladyshev, V.Yu. Svitich, M.E. Moiseev, V.A. Vetoshkin, S.S. Gnedash, G.B. Pavlinov, A.S. Skobaro
-
Long-term outcomes of neoadjuvant endocrine therapy versus chemotherapy in luminal HER2-breast cancer
DOI 10.31917/2501041
N.K. Abduloeva, V.M. Moiseenko, F.V. Moiseenko. O.A. Skripko, M.V. Scriabin, R.A. Ryanjina
-
MSI-H cancer – what has happened in the last year?
DOI 10.31917/2501034
V.A. Chubenko
-
Application of biomedical cell products based on natural killer cells and cytokine-induced killer cells for the treatment of oncological diseases
DOI 10.31917/2501025
A.O. Malasheuskaya, N.G. Antonevich, A.Y. Hancharou
-
Is it possible to get survival benefit in advanced malignant tumors? (datA from trials, critical aspects)
DOI 10.31917/2501017
A.I. Semenova
-
Optimal dosage and duration of treatment for patients with malignant tumors. are approved guidelines always correct?
DOI 10.31917/2501008
M.A. Krasavina, V.M. Moiseenko
-
Advances in fundamental and translational oncology: the year 2023 update
DOI 10.31917/2501001
E.N. Imyanitov
-
Rationale for systemic therapy administration in clinically localised tumors
DOI 10.31917/2404311
N.M. Volkov
-
Individualization of adjuvant therapy: who can I refuse?
DOI 10.31917/2404319
E.V. Karabina
-
Possibilities of cytostatics, hormonal and targeted therapy for operable tumors
DOI 10.31917/2404326
N.V. Levchenko
-
Immunotherapy: Neoadjuvant and/or adjuvant? Literature review
DOI 10.31917/2404337
N.A. Falaleeva, E.A. Bykova, L.Yu. Grivtsova, A.S. Belokhvostova, A.А. Danilenko, I.S. Pimonova, P.V. Shegai, S.A. Ivanov, A.D. Kaprin
-
Neoadjuvant and adjuvant radiotherapy: historical and practical aspects
DOI 10.31917/2404358
E.Y. Mozerova
-
Effectiveness of the alternative drugs and other factors in adjuvant treatment for the malignant tumors
DOI 10.31917/2404383
V.A. Chubenko
-
Neoadjuvant endocrine therapy for breast cancer: state of the art
DOI 10.31917/2404395
А.А. Zavialov, A.I. Tyryshkin, S.E. Varlamova.
-
Efficacy of neoadjuvant endocrine therapy in HR-positive/HER2-negative breast cancer: A review
DOI 10.31917/2404406
N.K. Abduloeva, V.M. Moiseenko, F.V. Moiseenko, O.A. Skripko, M.V. Scriabin, R.A. Ryandjina
-
The significance of the dynamics of PET biomarkers in assessing the response to R-CHOP immunochemotherapy in patients with diffuse large B-cell lymphoma
DOI 10.31917/2404412
Y.N. Vinogradova, M.S. Tlostanova, A.A. Ivanova, M.I. Zelyanina, N.V. Ilyin
-
Effect of surgical risk factors on the short-term outcomes for rectal cancer surgery. Laparoscopic or robotic approach?
DOI 10.31917/2404420
M.E. Moiseev, D.V. Gladyshev, V.A. Vetoshkin, S.A. Kovalenko, R.A. Murashko, S.Z. Hondziya, V.Yu. Svitich, S.S. Gnedash
-
Local treatment options for colorectal cancer patients with lung metastases: a literature review
DOI 10.31917/2404430
T.S. Boldyreva, М.Е. Ivannikov, Y.S. Yesakov, V.K. Lyadov